Evidence map›Paper›PMID 32619518›Full record

ArticleCell stem cell2020

Wnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived Cardiomyocytes.

Jan W Buikema, Soah Lee, William R Goodyer, Renee G Maas, Orlando Chirikian, Guang Li, Yi Miao, Sharon L Paige, Daniel Lee, Haodi Wu and 27 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 2 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 2 syntheses or guidelines pooled it, 225 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Signaling pathways regulating cardiac regeneration.Cell regeneration (London, England) · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. An organic artificial cardiomyocyte.Nature communications · 2026
    Article
  15. Article
  16. Mechanisms and Therapeutic Potential of Human Cardiomyocyte Proliferation.Journal of cardiovascular development and disease · 2026
    Review
  17. Review
  18. Review
  19. Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 8 institutions in 3 countries.

Jan W BuikemaCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Utrecht Regenerative Medicine Center, Circulatory Health Laboratory, University Utrecht, Department of Cardiology, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands.
Soah LeeCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
William R GoodyerCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Pediatric Cardiology, Department of Pediatrics, Stanford School of Medicine, Stanford, CA 94305, USA.
Renee G MaasUtrecht Regenerative Medicine Center, Circulatory Health Laboratory, University Utrecht, Department of Cardiology, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands.
Orlando ChirikianCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Guang LiCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Yi MiaoDepartment of Molecular and Cellular Physiology, Howard Hughes Medical Institute, and Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Sharon L PaigeCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Pediatric Cardiology, Department of Pediatrics, Stanford School of Medicine, Stanford, CA 94305, USA.
Daniel LeeCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Haodi WuCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
David T PaikCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Siyeon RheeDepartment of Biology, Stanford University, Stanford, CA 94305, USA.
Lei TianCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Francisco X GaldosCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Nazan PulucaCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Benjamin BeyersdorfCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
James HuCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Aimee BeckCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Sneha VenkamatranCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Srilatha SwamiDivision of Endocrinology and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Paul WijnkerAmsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Maike SchuldtAmsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Larissa M DorschAmsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Alain van MilUtrecht Regenerative Medicine Center, Circulatory Health Laboratory, University Utrecht, Department of Cardiology, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands.
Kristy Red-HorseCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Biology, Stanford University, Stanford, CA 94305, USA.
Joy Y WuDivision of Endocrinology and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Caroline GeisenInstitute of Physiology I, Life and Brain Center, Medical Faculty, University of Bonn, 53105 Bonn, Germany.
Michael HesseInstitute of Physiology I, Life and Brain Center, Medical Faculty, University of Bonn, 53105 Bonn, Germany.
Vahid SerpooshanCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, GA 30322, USA.
Stefan JovingeDeVos Cardiovascular Research Program of Spectrum Health and Van Andel Research Institute, 100 Michigan Street NE, Grand Rapids, MI 49503, USA; Michigan State University, College of Human Medicine, 15 Michigan Street NE, Grand Rapids, MI, USA.
Bernd K FleischmannInstitute of Physiology I, Life and Brain Center, Medical Faculty, University of Bonn, 53105 Bonn, Germany.
Pieter A DoevendansUtrecht Regenerative Medicine Center, Circulatory Health Laboratory, University Utrecht, Department of Cardiology, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands; Netherlands Heart Institute, Holland Heart House, 3511 EP Utrecht, the Netherlands.
Jolanda van der VeldenAmsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
K Christopher GarciaDepartment of Molecular and Cellular Physiology, Howard Hughes Medical Institute, and Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Joseph C WuCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Joost P G SluijterUtrecht Regenerative Medicine Center, Circulatory Health Laboratory, University Utrecht, Department of Cardiology, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands.
Sean M WuCardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: smwu@stanford.edu.
Stanford University · USCardiovascular Institute of the South · USAmsterdam University Medical Centers · NLUniversity Medical Center Utrecht · NLLife & Brain (Germany) · DEStanford Medicine · USUniversity of Bonn · DEVan Andel Institute · US

Funding

Project 3 (Mercola)P01HL141084 · NHLBI · STANFORD UNIVERSITY · PI Joseph C. Wu · 2019 to 2026
$21.1M
From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motorRM1GM131981 · NIGMS · STANFORD UNIVERSITY · PI BERNSTEIN, DANIEL, MACK, DAVID LEE · 2019 to 2023
$10.3M
Induced pluripotent stem cells in the understanding and treatment of heart diseaseU01HL099776 · NHLBI · STANFORD UNIVERSITY · PI LONGAKER, MICHAEL T, WU, JOSEPH C. · 2009 to 2015
$8.2M
Single Cell Sequencing of Human iPSC-CM Subtype Identity and FunctionR01HL145676 · NHLBI · STANFORD UNIVERSITY · PI MARK MERCOLA, Joseph C. Wu · 2019 to 2026
$5.1M
Human iPSC Model to Elucidate Metabolic Interplay in Diabetic CardimyopathyR01HL146690 · NHLBI · STANFORD UNIVERSITY · PI LIAO, RONGLIH, MERCOLA, MARK · 2019 to 2025
$5.1M
Enabling Technologies for Human-Machine Hybrid TissuesDP1LM012179 · NLM · STANFORD UNIVERSITY · PI WU, SEAN M · 2014 to 2018
$3.8M
Generation of functional organs via developmental chimerismDP2OD004411 · OD · STANFORD UNIVERSITY · PI WU, SEAN M · 2008 to 2008
$2.5M
Cellular and Molecular Mechanisms of Atrial Cardiomyocyte Lineage Commitment R00HL133472 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LI, GUANG · 2019 to 2021
$750k
High Throughput DNA Sequencer UpgradeS10OD018220 · OD · STANFORD UNIVERSITY · PI COLLER, JOHN · 2014 to 2014
$596k
Identifying Angiocrine Factors for Cardiomyocyte Maturation Using Single-Cell SequencingK99HL150216 · NHLBI · STANFORD UNIVERSITY · PI PAIK, DAVID T · 2020 to 2021
$325k
Molecular and Cellular Mechanisms of Neonatal Cardiac Development and RepairK99HL127295 · NHLBI · STANFORD UNIVERSITY · PI SERPOOSHAN, VAHID · 2016 to 2017
$238k
Patient-Specific Induced Pluripotent Stem Cells for Modeling Single Ventricle Congenital Heart DiseaseK08HL148553 · NHLBI · STANFORD UNIVERSITY · PI PAIGE, SHARON LYNN · 2019 to 2020
$212k
NHLBI NIH HHS F30 HL149152NHLBI NIH HHS F32 HL142205NHLBI NIH HHS K08 HL148553NHLBI NIH HHS K99 HL127295NHLBI NIH HHS K99 HL150216NHLBI NIH HHS P01 HL141084NHLBI NIH HHS R00 HL133472NHLBI NIH HHS R01 HL145676NHLBI NIH HHS R01 HL146690NHLBI NIH HHS U01 HL099776NIGMS NIH HHS RM1 GM131981NIH HHS DP2 OD004411NIH HHS S10 OD018220NLM NIH HHS DP1 LM012179
6 · The paper itself

Abstract

Modulating signaling pathways including Wnt and Hippo can induce cardiomyocyte proliferation in vivo. Applying these signaling modulators to human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) in vitro can expand CMs modestly (<5-fold). Here, we demonstrate massive expansion of hiPSC-CMs in vitro (i.e., 100- to 250-fold) by glycogen synthase kinase-3β (GSK-3β) inhibition using CHIR99021 and concurrent removal of cell-cell contact. We show that GSK-3β inhibition suppresses CM maturation, while contact removal prevents CMs from cell cycle exit. Remarkably, contact removal enabled 10 to 25 times greater expansion beyond GSK-3β inhibition alone. Mechanistically, persistent CM proliferation required both LEF/TCF activity and AKT phosphorylation but was independent from yes-associated protein (YAP) signaling. Engineered heart tissues from expanded hiPSC-CMs showed comparable contractility to those from unexpanded hiPSC-CMs, demonstrating uncompromised cellular functionality after expansion. In summary, we uncovered a molecular interplay that enables massive hiPSC-CM expansion for large-scale drug screening and tissue engineering applications.

Indexed as

Induced Pluripotent Stem CellsCell DifferentiationCells, CulturedGlycogen Synthase Kinase 3 betaHumansMyocytes, CardiacGlycogen Synthase Kinase 3 betacardiomyocytesexpansionGSK3induced pluripotent stem cellsmaturationproliferationWnt signaling

Identifiers

PMID32619518
PMCPMC7334437
OpenAlexW3040598213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.